Science Explorer Back to mapMap
Discussion
Researcher · Noxxon Pharma (Germany) · Germany

Frank Schwoebel

Frank Schwoebel publishes mostly in Molecular Biology, Immunology and Hematology, on topics such as Iron Metabolism and Disorders, Cancer-related molecular mechanisms research and Cell death mechanisms and regulation.

OpenAlex
World rank
#2,762,057
of 7,710,434 ranked researchers
Rank in Germany
#137,029
of 364,343
Works
21
Citations
668
Citations per work
31.8
h-index
11
i10-index 11Top 71% in Molecular Biology
Frank Schwoebel

What does Frank Schwoebel research?

Frank Schwoebel's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Medicine (28%), Immunology and Microbiology (16%).

Life Sciences: 10 works · 45.7% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 29.9% of their workMolecular Biology: 5 works · 24.6% of their workCancer Research: 1 works · 5.3% of their workImmunology and Microbiology: 3 works · 15.8% of their workImmunology: 3 works · 15.8% of their workHealth Sciences: 6 works · 28.0% of their workMedicine: 6 works · 28.0% of their workHematology: 3 works · 14.0% of their workGenetics: 1 works · 7.0% of their workOncology: 1 works · 7.0% of their workEverything else: 6 works · 26.3% of their workTHEIR WORKFrank Schwoebel21works
Life Sciences46%Health Sciences28%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology629.9%
    2. Immunology and Microbiology315.8%
    1. Medicine628.0%
  3. Everything else626.3%
  1. 1Molecular Biology25% of their works
  2. 2Immunology16% of their works
  3. 3Hematology14% of their works
  4. 4Oncology7% of their works
  5. 5Genetics7% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Frank Schwoebel's research?

The keywords of their largest research topics: Hepcidin, Iron Regulation, Cancer Therapy, Cancer Immunotherapy, Apoptosis, Cancer, Cell Death and Long Noncoding RNAs.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Hepcidin61 topic
  2. Iron Regulation61 topic
  3. Cancer Therapy52 topics
  4. Cancer Immunotherapy42 topics
  5. Apoptosis31 topic
  6. Cancer31 topic
  7. Cell Death31 topic
  8. Long Noncoding RNAs31 topic
  9. Sickle-cell Disease31 topic
  10. Thalassemia31 topic
  11. CD4721 topic
  12. Dendritic Cells21 topic
  13. Immunity21 topic
  14. Protein Kinases21 topic
  15. RNA methylation21 topic
  16. Ras Signaling21 topic
  17. apoptotic cells21 topic
  18. m6A-seq21 topic

Where does Frank Schwoebel work?

Frank Schwoebel's main affiliation in the publication record is Noxxon Pharma (Germany), Germany.

How many publications and citations does Frank Schwoebel have?

OpenAlex counts 21 works and 668 citations for Frank Schwoebel, an h-index of 11, ranking #2,762,057 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Frank Schwoebel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.